US stocks starting with V
The official accounts of 73 companies listed in the United States whose name starts with V: revenue and net profit for the latest fiscal year, as stated in the annual report (Form 10-K) each one files with the SEC, in US dollars. Each one links to its page, with the document every figure comes from.
| Company | Ticker | Fiscal year | Revenue | Net profit |
|---|---|---|---|---|
| V. F | NYSE: VFC | 2026 | $9,605m | $254.9m |
| V2X | NYSE: VVX | 2025 | $4,480m | $77.9m |
| Vaalco Energy | NYSE: EGY | 2025 | $359.3m | −$41.4m |
| Vail Resorts | NYSE: MTN | 2026 | $2,838m | $147.5m |
| Valaris | NYSE: VAL | 2025 | $2,369m | $982.8m |
| Vale | NYSE: VALE | 2025 | $38,403m | $2,352m |
| Valero Energy | NYSE: VLO | 2025 | $122,687m | $2,348m |
| Valhi | NYSE: VHI | 2025 | $2,077m | −$57.6m |
| Valley National Bancorp | NASDAQ: VLY | 2025 | $2,026m | $598.0m |
| Valmont Industries | NYSE: VMI | 2025 | $4,104m | $350.3m |
| Value Line | NASDAQ: VALU | 2026 | $33.4m | $21.6m |
| Valvoline | NYSE: VVV | 2025 | $1,710m | $210.7m |
| Vanda Pharmaceuticals | NASDAQ: VNDA | 2025 | $216.1m | −$220.5m |
| Varex Imaging | NASDAQ: VREX | 2025 | $844.6m | −$70.3m |
| Varonis Systems | NASDAQ: VRNS | 2025 | $623.5m | −$129.3m |
| Vaxcyte | NASDAQ: PCVX | 2025 | — | −$766.6m |
| Veeco Instruments | NASDAQ: VECO | 2025 | $664.3m | $35.4m |
| Veeva Systems | NYSE: VEEV | 2026 | $3,195m | $908.9m |
| Velo3D | NASDAQ: VELO | 2025 | $46.0m | −$71.4m |
| Velocity Financial | NYSE: VEL | 2025 | $185.8m | $105.1m |
| Ventas | NYSE: VTR | 2025 | $5,834m | $261.5m |
| Venu | NYSE: VENU | 2025 | $17.9m | −$44.1m |
| Vera Therapeutics | NASDAQ: VERA | 2025 | — | −$299.6m |
| Veracyte | NASDAQ: VCYT | 2025 | $517.1m | $66.4m |
| Veralto | NYSE: VLTO | 2025 | $5,503m | $940.0m |
| Verastem | NASDAQ: VSTM | 2025 | $30.9m | −$209.5m |
| Vericel | NASDAQ: VCEL | 2025 | $276.3m | $16.5m |
| VeriSign | NASDAQ: VRSN | 2025 | $1,657m | $825.7m |
| Verisk Analytics | NASDAQ: VRSK | 2025 | $3,073m | $908.3m |
| Veritone | NASDAQ: VERI | 2025 | $92.2m | −$111.7m |
| Verizon | NYSE: VZ | 2025 | $138,191m | $17,174m |
| Verra Mobility | NASDAQ: VRRM | 2025 | $979.1m | $136.6m |
| Vertex | NASDAQ: VERX | 2025 | $748.4m | $7.2m |
| Vertex Pharmaceuticals | NASDAQ: VRTX | 2025 | $12,001m | $3,953m |
| Vertiv | NYSE: VRT | 2025 | $10,230m | $1,333m |
| Vestis | NYSE: VSTS | 2025 | $2,735m | −$40.2m |
| Viant Technology | NASDAQ: DSP | 2025 | $344.2m | $8.4m |
| Viasat | NASDAQ: VSAT | 2026 | $4,640m | −$34.1m |
| Viatris | NASDAQ: VTRS | 2025 | $14,300m | −$3,515m |
| Viavi Solutions | NASDAQ: VIAV | 2026 | $1,518m | −$30.4m |
| Vici Properties | NYSE: VICI | 2025 | $4,006m | $2,775m |
| Victoria's Secret | NYSE: VSXY | 2026 | $6,553m | $161.0m |
| Victory Capital | NASDAQ: VCTR | 2025 | $1,306m | $330.1m |
| Viemed Healthcare | NASDAQ: VMD | 2025 | $270.3m | $14.9m |
| Village Super Market | NASDAQ: VLGEA | 2026 | $2,406m | $52.5m |
| Vir Biotechnology | NASDAQ: VIR | 2025 | $68.6m | −$438.0m |
| Virgin Galactic | NYSE: SPCE | 2025 | $1.5m | −$278.9m |
| Virginia National Bankshares | NASDAQ: VABK | 2025 | $57.6m | $19.3m |
| Viridian Therapeutics | NASDAQ: VRDN | 2025 | $70.8m | −$342.6m |
| Virtu Financial | NYSE: VIRT | 2025 | $3,632m | $468.4m |
| Virtus Investment Partners | NYSE: VRTS | 2025 | $852.9m | $136.0m |
| Visa | NYSE: V | 2026 | $45,903m | $23,504m |
| Vishay Intertechnology | NYSE: VSH | 2025 | $3,069m | −$9.0m |
| Vishay Precision Group | NYSE: VPG | 2025 | $307.2m | $5.3m |
| Vista Energy | NYSE: VIST | 2025 | $2,474m | $719.1m |
| Vista Gold | NYSE: VGZ | 2025 | $0.0m | −$7.5m |
| Vistance Networks | NASDAQ: VISN | 2025 | $1,932m | $2,284m |
| Visteon | NASDAQ: VC | 2025 | $3,768m | $201.0m |
| Vistra | NYSE: VST | 2025 | $17,738m | $944.0m |
| Vita Coco | NASDAQ: COCO | 2025 | $609.8m | $71.3m |
| Vital Farms | NASDAQ: VITL | 2025 | $759.4m | $66.3m |
| Vitesse Energy | NYSE: VTS | 2025 | $274.0m | $25.3m |
| Vivid Seats | NASDAQ: SEAT | 2025 | $450.5m | $806.1m |
| Vivmark Residential | NYSE: VMRK | 2025 | $3,094m | $1,120m |
| Volaris | NYSE: VLRS | 2025 | — | −$103.9m |
| Vontier | NYSE: VNT | 2025 | $3,076m | $406.1m |
| Vor Biopharma | NASDAQ: VOR | 2025 | — | −$696.0m |
| Vornado Realty Trust | NYSE: VNO | 2025 | $1,810m | $905.0m |
| Voya Financial | NYSE: VOYA | 2025 | $8,189m | $654.0m |
| Voyager Therapeutics | NASDAQ: VYGR | 2025 | $40.4m | −$119.7m |
| VSE | NASDAQ: VSEC | 2025 | $1,112m | $11.7m |
| Vulcan Materials | NYSE: VMC | 2025 | $7,941m | $1,077m |
| Vuzix | NASDAQ: VUZI | 2025 | $6.3m | −$32.3m |
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell.